Correlation Between Anebulo Pharmaceuticals and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Anebulo Pharmaceuticals and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anebulo Pharmaceuticals and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Anebulo Pharmaceuticals and Cue Biopharma, you can compare the effects of market volatilities on Anebulo Pharmaceuticals and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anebulo Pharmaceuticals with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anebulo Pharmaceuticals and Cue Biopharma.
Diversification Opportunities for Anebulo Pharmaceuticals and Cue Biopharma
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Anebulo and Cue is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Anebulo Pharmaceuticals and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Anebulo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anebulo Pharmaceuticals are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Anebulo Pharmaceuticals i.e., Anebulo Pharmaceuticals and Cue Biopharma go up and down completely randomly.
Pair Corralation between Anebulo Pharmaceuticals and Cue Biopharma
Given the investment horizon of 90 days Anebulo Pharmaceuticals is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Anebulo Pharmaceuticals is 2.41 times less risky than Cue Biopharma. The stock trades about -0.07 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 139.00 in Cue Biopharma on November 4, 2024 and sell it today you would earn a total of 6.00 from holding Cue Biopharma or generate 4.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Anebulo Pharmaceuticals vs. Cue Biopharma
Performance |
| Timeline |
| Anebulo Pharmaceuticals |
| Cue Biopharma |
Anebulo Pharmaceuticals and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Anebulo Pharmaceuticals and Cue Biopharma
The main advantage of trading using opposite Anebulo Pharmaceuticals and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anebulo Pharmaceuticals position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Anebulo Pharmaceuticals vs. Adagene | Anebulo Pharmaceuticals vs. Acrivon Therapeutics, Common | Anebulo Pharmaceuticals vs. AnaptysBio | Anebulo Pharmaceuticals vs. Mineralys Therapeutics, Common |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |